Insulin is a vital hormone that regulates blood sugar. It is produced by beta cells in the pancreas. Insulin helps glucose enter cells for energy or storage. When insulin is insufficient, glucose builds up in the blood. This can lead to conditions like diabetes.
Understanding How Insulin Works
Insulin acts like a key for your cells. It unlocks cells in the liver, muscles, and fat tissue. This allows glucose to enter and be used or stored. This process effectively lowers blood glucose levels. In contrast, glucagon, another pancreatic hormone, releases stored glucose when blood sugar is low.
Different Kinds of Insulin and How They Act
Insulin preparations vary in how fast they work. They also differ in their peak effect and duration. This allows for customized treatment plans.
Rapid-acting insulin
- Onset: 10-20 minutes
- Peak: 1-2 hours
- Duration: 2-4 hours
- Purpose: Taken with meals to manage glucose spikes.
- Examples:
- Insulin lispro (Humalog)
- Insulin aspart (NovoLog)
- Insulin glulisine (Apidra)
- Inhaled insulin (Afrezza): Very rapid; typically used before meals with long-acting insulin.
Short-acting insulin
- Onset: 30 minutes
- Peak: 2-3 hours
- Duration: 3-6 hours
- Timing: Take 30-60 minutes before meals.
- Examples: Humulin R, Novolin R
- Note: Actrapid is for intravenous use; not short or quick-acting despite its name.
Intermediate-acting insulin
- Onset: 1-2 hours
- Peak: 4-12 hours
- Duration: 12-18 hours
- Purpose: Provides background insulin for about half a day.
- Example: NPH insulin (Humulin N, Novolin N)
Long-acting insulin
- Onset: 1.5-2 hours
- Peak: None pronounced
- Duration: Up to 24 hours
- Purpose: Provides steady, all-day basal insulin coverage.
- Examples: Insulin glargine (Lantus, Basaglar), Insulin detemir (Levemir)
Ultra-long-acting insulin
- Onset: Several hours
- Peak: None
- Duration: 36 hours or longer (up to 42 hours for Tresiba)
- Purpose: Provides extended basal insulin coverage.
- Examples:
- Insulin degludec (Tresiba)
- Glargine U-300 (Toujeo)
- Note on Toujeo: High concentration insulin for better absorption; U100 insulin absorption can be unreliable beyond 50-60 units.
Premixed insulin
- Composition: Combines rapid/short-acting and intermediate/long-acting insulins.
- Timing: Taken twice daily before meals.
- Common Ratios:
- 30% short and 70% long (e.g., Humulin M3, NovoMix 30).
- Other ratios available.
- Specific Uses:
- Humulin Mix25 or Mix50: Used for post-injection hypo or hyperglycemia within 6 hours.
- Humulin Mix 50: Often given three times daily with each meal.
How to Administer Insulin Effectively
Insulin cannot be taken by mouth because digestion breaks it down. It is usually injected into the fatty tissue under the skin.
- Methods of delivery include syringes and pens. Insulin pumps are small computerized devices that deliver continuous, programmed doses of insulin through a catheter placed under the skin. Inhalers deliver ultra-rapid-acting insulin through inhalation.
- To minimize pain, use a new, sharp needle for each injection. Allow insulin to reach room temperature before injecting. Inject at a 90-degree angle and rotate sites.
- Common injection sites are the abdomen, upper arms, upper legs, and buttocks. Rotating sites prevents fat lumps or depressions, which can affect insulin absorption.
- Store unopened insulin in the refrigerator. Opened vials and pens can be kept at room temperature (below 25°C or 77°F) for up to 28-30 days. Keep them away from direct heat and sunlight. Do not use frozen, overheated, or expired insulin.
Insulin’s Role in Health Conditions
Insulin therapy is crucial for managing diabetes.
- Type 1 Diabetes: People with type 1 diabetes make little to no insulin due to the autoimmune destruction of pancreatic beta cells. They need lifelong insulin therapy. In Type 1 diabetes, a basal bolus regimen is usually used to replace the lacking insulin, which involves basal or background insulin (once daily long or twice daily intermediate) and short-acting insulin for meals (e.g., NovoRapid 15 minutes before food). Typically, T1 diabetics require 50% long and 50% short (e.g., 12 units basal, 4 units NovoRapid with meals), though specific dosing varies significantly and requires careful titration.
- Type 2 Diabetes: In type 2 diabetes, the body either doesn’t make enough insulin or doesn’t use it well. While initial management may involve lifestyle changes and oral medications, many individuals eventually require insulin therapy to control blood sugar levels and prevent complications. When insulin is required, once daily intermediate insulin is often used to help offload the pancreas’ work. However, a high HbA1c (e.g., over 96mmol/mol) can suggest that a lot of help is required, in which case twice daily mixed insulin (with breakfast and dinner, suggesting most carbohydrates be eaten during these meals) or basal bolus (for greater flexibility) may be used.
- Insulinomas: These rare pancreatic tumors produce too much insulin, leading to frequent and severe low blood sugar (hypoglycemia). Surgery can usually cure most cases.
- Insulin Spikes: Frequent large insulin spikes can lead to insulin resistance. Managing carbohydrate intake helps moderate these spikes.
Potential Side Effects and How to Manage Them
Insulin therapy can have side effects.
- Hypoglycemia (low blood sugar) is the most common side effect. It occurs with too much insulin relative to glucose. Symptoms include sweating, dizziness, and confusion. Consuming fast-acting carbohydrates treats it.
- Weight gain can happen as insulin promotes glucose storage. Diet and exercise can help manage this. Initial weight gain is manageable with diet and exercise.
- Injection site reactions like redness or swelling can occur, especially if sites are not rotated properly.
- Allergic reactions are rare, but can cause localized skin reactions or, very rarely, systemic symptoms.
- Other complications from uncontrolled blood sugar, whether too high or too low, can affect the heart, kidneys, eyes, and nerves. Some studies suggest an increased risk of heart attack, stroke, and certain cancers with long-term insulin use in type 2 diabetes, but the benefits often outweigh these risks for those who need insulin.
- The real risk of hyperglycemia is Diabetic Ketoacidosis (DKA), which should be unlikely unless the patient is T1 without basal insulin, as only a trickle of insulin is needed to prevent ketosis. Another risk is dehydration resulting in Hyperosmolar Hyperglycemic State (HHS), which adequate hydration can prevent.
Common Misunderstandings About Insulin
Some common misconceptions about insulin exist.
- “Insulin can cure diabetes.” Currently, insulin manages diabetes; it does not cure it.
- “Insulin injections are painful.” Modern needles and pens minimize discomfort.
- “Insulin always causes severe weight gain.” Initial weight gain is manageable with diet and exercise.
Effective insulin management requires working with healthcare professionals. Regular blood sugar monitoring and adherence to regimens are also key. This allows individuals to live full lives.
Recent Advances in Insulin Research
New research is changing how insulin is used.
- Smart insulins activate only when blood sugar is high. This reduces hypoglycemia risk.
- Ultra-rapid and ultra-long-acting insulins offer more flexibility. They also provide better blood sugar stability.
- Novel delivery methods include inhaled insulins. Oral or patch-based systems are also being researched. These aim to improve convenience.
Benefits and Limitations of Insulin Therapy
Insulin therapy has both strengths and weaknesses.
- Strengths:
- Effective blood sugar control: Insulin is reliable for reducing blood glucose. This is true for type 1 and advanced type 2 diabetes.
- Flexible dosing: Newer insulins allow for more tailored regimens. This reduces the risk of low blood sugar.
- Smart insulins: These promise fewer hypoglycemic episodes. They also reduce the need for constant monitoring.
- Weaknesses:
- Risk of hypoglycemia: This is a risk, especially with older insulins. Incorrect dosing also increases this risk.
- Weight gain: Insulin can promote fat storage.
- Injection burden: Regular injections or pump use can be inconvenient.
- Complexity: It requires careful timing, dosing, and meal planning.
Insulin’s Life-Saving Benefits
Insulin provides significant benefits for those who need it.
- Essential for Type 1 Diabetes: It is life-saving for all people with type 1 diabetes.
- Prevents Complications: Good glucose control lowers the risk of long-term complications. These include kidney, eye, and nerve damage.
- Improved Quality of Life: Newer insulins offer more flexibility. They also have fewer side effects, improving quality of life.
Alternatives to Insulin
Several alternatives exist, especially for type 2 diabetes.
- Oral Medications: Metformin and SGLT2 inhibitors are examples.
- Non-Insulin Injectables: GLP-1 receptor agonists offer glucose control and weight loss.
- Artificial Pancreas Systems: These automate insulin delivery using pumps and continuous glucose monitors. The newer hybrid closed loops are like variable rates “sliding scales” in that they change based on the glucose—except with variable rates, nurses check the glucose every hour and change the rate, whereas with pumps, it checks every minute and varies, allowing for excellent control.
- Stem Cell Therapy: Early research aims to restore natural insulin production. This is not yet widely available.
- Lifestyle Interventions: Diet, exercise, and weight loss can reduce insulin needs. They can also delay progression in type 2 diabetes.
- Complementary Approaches: Some herbs and supplements show promise. These should only be used with medical guidance.
Individual needs and risks vary for all diabetes treatments. Always make decisions with a healthcare provider.
Advanced Considerations: SGLT2 Inhibitors and DKA Risk
While generally beneficial, SGLT2 inhibitors come with specific considerations, particularly regarding Diabetic Ketoacidosis (DKA). Daily ketone testing for patients on SGLT2 inhibitors may be excessive, but the risk of DKA is about doubled in diabetics taking these medications. This means going from roughly 2 per 1000 patient-years to 4 per 1000 patient-years based on outpatient follow-up. This translates to significant numbers, especially in acute care settings with patients presenting with poor oral intake, reduced mobility, delirium, and deranged bloods, often with suspected infections like UTIs or pneumonia, who might not be candidates for intensive care. Special attention is required as euglycaemic DKA (DKA with normal or near-normal blood glucose levels) can occur, making it harder to diagnose. In cases of acute illness, some clinicians might temporarily discontinue SGLT2 inhibitors due to concerns about reliably picking up DKA in less acutely monitored settings.
Remember that hyperglycemia is often a sign of illness, like tachycardia or a high respiratory rate.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making changes to your insulin regimen.
About the Author
The author is an independent educator and solo researcher committed to making complex topics clear and engaging. With a Master’s in Computer Science and multiple technical certifications, he brings a rigorous, research-driven approach to his work. His passion for teaching spans both computer and science subjects, reflecting broad expertise and strong research skills. Through meticulous analysis and clear communication, he aims to deliver accurate, trustworthy content to readers.
Very informative and comprehensive article.